ABSTRACT Myocardial thallium-201 (201T1) uptake and clearance after intravenous administration of dipyridamole (150 jig/kg) were determined in 12 open-chest anesthetized dogs with a partial coronary artery stenosis. 201TI (1.5 mCi) was injected intravenously and myocardial biopsy specimens were obtained 10 min, 60 min, and 2 hr after injection. Serial changes in 201.T1 activity in the normal zone and in the zone of partial stenosis were correlated with microsphere-determined regional blood flow and distal coronary pressure. Another nine dogs with equivalent stenosis not given dipyridamole before 201TI served as controls. In the 12 dogs given dipyridamole, 201TI activity at 10 min in the zone of stenosis was reduced to 42 ± 5% of initial normal zone activity (p < .001) and remained at 44 ± 3% of initial normal zone activity at 2 hr. There was a good correlation (.81) between the percent reduction in myocardial 201TI activity and the percent reduction of peak hyperemic flow as determined by measuring the percentage difference in peak coronary flow after a transient 10 sec occlusion under control and stenotic conditions. In contrast, 201TI clearance was rapid in the normal zone, with 201T1 activity decreasing to 55 ± 3% of initial normal zone activity by 2 hr. A redistribution pattern was produced because of the disparate clearance rates from hyperperfused and relatively hypoperfused myocardial regions. The relative 201TI defect decreased from 58% to 1 1% from 10 min to 2 hr. In the normal zone dipyridamole increased epicardial flow from 1.03 0.09 (SEM) to 3.52 0.36 ml/min/ g (p < .0001) and endocardial flow from 1. 19 ± 0.09 to 2.96 0.20 ml/min/g (p = .0001). In the zone of partial stenosis the increase in epicardial flow after dipyridamole was less marked (1.01 ± 0.10 to 1.55 + 0.15 ml/min/g; p = .009) and endocardial flow decreased (0. 84 + 0. 11 to 0.64 + 0.15 ml/ min/g; p = .04). Coronary perfusion pressure distal to the stenotic zone fell from 65 ± 3 to 50 ± 3 mm Hg after dipyridamole. In the nine control dogs with equivalent stenosis, 201TI uptake and washout were not significantly different in the stenotic zone compared with the normal zone. These data indicate that dipyridamole-induced vasodilation in the presence of a partial stenosis results in diminished uptake and delayed clearance compared with increased uptake and more rapid clearance in normally perfused myocardium producing an initial 201TI defect with delayed redistribution. Our data further demonstrate that the magnitude of the initial decrease in 201TI uptake after dipyridamole correlates well with the percent reduction in coronary flow relative to the peak hyperemic flow response. Circulation 68, No. 6, 1328No. 6, -1338No. 6, , 1983 SYMPTOM-LIMITED EXERCISE is routinely used in conjunction with thallium-201 (201T1) myocardial imaging for detection and evaluation of coronary artery disease. Adequate stress is essential, since coronary artery disease will reduce the reserve capacity of the stenotic vessel long before there is significant reduction in resting blood flow. An abnormal perfusion
unable to perform adequate exercise. In addition, if maximal vasodilation can be achieved, then the magnitude of the resulting myocardial defect may reflect the physiologic severity of the disease independent of the level of exercise achieved.
There are several questions concerning the use of myocardial 201T1 scintigraphy with dipyridamole as an alternative to exercise. First, substantially increasing myocardial blood flow by vasodilation could alter the myocardial extraction of 201TI so that uptake would not correctly indicate the resulting distribution in myocardial blood flow. Second, the effect of dipyridamole on blood flow in myocardial regions supplied by stenotic vessels is not well understood. Finally, the amount and significance of 201T1 redistribution on delayed images may be significantly altered by the administration of intravenous dipyridamole. Evidence of redistribution of 201T1 in delayed images after exercise stress has been suggested to indicate viable muscle that was hypoperfused during exercise.'3 Redistribution has also been reported after dipyridamole infusion and one might expect the mechanism of redistribution to be the same. '4, 15 However, the induced maldistribution of blood flow is maintained for some time by the persistence of the vasodilatory effect of dipyridamole, whereas the abrupt termination of exercise may allow a more rapid renormalization of myocardial blood flow distribution. This may influence redistribution, although we have previously suggested that redistribution is rate limited by cell membrane exchange and should not be primarily dependent on the rate of renormalization of myocardial blood flow. If this model is correct, the process of redistribution after dipyridamole infusion would be similar to that after exercise.
The following experiments were performed to address these questions in the animal preparation. In this canine preparation, a stenosis was produced on the left anterior descending artery, which maintained normal or near-normal resting blood flow but eliminated most of the capacity for reactive hyperemia. Initial uptake and\net clearance of intravenously administered 201T1 were\then determined in a control group of dogs with stenoses that were not given dipyridamole and in a similar group of dogs receiving dipyridamole. We tested the hypothesis that the magnitude of a 201TI defect produced by dipyridamole infusion can be used as an indicator of the physiologic severity of a coronary artery narrowing. We also sought to determine the redistribution kinetics of myocardial 201TI The microsphere suspension was injected as a bolus over 5 to 10 sec into the left atrium, after which the injection catheter was flushed with 3 to 5 ml of 0.9% saline with constant monitoring of arterial pressure, coronary blood flow, distal coronary pressure, and heart rate. This procedure was repeated for each dose. Duplicate timed withdrawals from the two femoral artery cath-eters were begun 10 to 15 sec before the microsphere injection and continued for a total of 90 sec. Blood samples from each withdrawal were divided among three or four tared tubes.
At the end of the experiment, the animal was killed and the left ventricle and septum were separated from the remainder of the heart, trimmed of epicardial fat and vessels, and divided into four layers from apex to base. Each layer was then cut into eight transmural specimens. The sites from which myocardial biopsy specimens were taken were recorded on a map of the epicardial surface of the left ventricle, and the specific specimens used for needle biopsies were identified for subsequent correlations between flow and 201TI activity. Each specimen was further subdivided into epicardial, midwall, and endocardial sections. The resulting 96 samples were weighed and counted, together with the duplicate withdrawals and pure isotope samples, for 500 sec in a Packard Gamma Auto Scintillation Counter. A multichannel analyzer was used with the following four windows: 46Sc = 740 to 1300 KeV; 95Nb = 650 to 818 KeV; '03Ru = 450 to 570
KeV; 113Sn = 340 to 440 KeV. injection, hemodynamic recordings were again made. Immediately thereafter a second set of transmural needle biopsy specimens were obtained from the same regions. This entire procedure was repeated 2 hr after 201T1 administration. The third set of microspheres was injected, and immediately thereafter the final biopsy specimens were obtained, this time in duplicate, from stenotic and nonischemic regions. The animals were then killed and the hearts were removed for examination as described above.
Dipyridamole group. Another 12 dogs underwent production of the partial coronary stenosis in the manner described for control animals. The severity of stenosis was assessed by the percent reduction in peak hyperemic flow after a 10 sec transient occlusion of the LAD achieved with the snare placed distal to the hydraulic occluder and flow meter. Hemodynamic measurements and blood flow determinations were obtained with the stenosis in place. Dipyridamole was then infused in the femoral vein at a dose of 0. 15 mg/kg over a period of I min. During the infusion, aortic pressure, heart rate, distal LAD pressure, left atrial pressure, and electromagnetically determined coronary flow were continuously monitored. Four minutes after dipyridamole infusion the second set of microspheres was injected and femoral reference samples were withdrawn. Immediately thereafter a dose of 1.5 mCi of 201T1 was administered intravenously. Ten minutes later, transmural biopsy specimens were obtained from the central LAD region and from the nonischemic zone perfused by branches of the unstenosed circumflex area.
This procedure was again repeated at 2 hr after 201TI administration just before the animal was killed. Duplicate biopsy specimens of the stenotic and nonischemic regions were obtained in 11 of the 12 dogs at this final stage. In the remaining dog, only single biopsies were performed. As described for control dogs, the hearts were excised and multiple myocardial specimens from the left ventricle were processed for gamma well scintillation counting for with the same stenosis in place. This value for defining severity of stenosis was adopted to characterize the actual hemodynamic impact of the obstruction independently of its anatomic structure. Statistical analysis. In control and dipyridamole groups, a t statistic from paired observations was used to test for differences between experimental conditions. An unpaired t statistic was calculated to identify differences between mean values in groups or between means of myocardial zones within a group under different treatment conditions. The average R2 was calculated from linear regression for the duplicate myocardial biopsies of the stenotic and normal regions to determine the percentage of variation held in common for the two measurements of 201T1 activity. This provided a "reliability percentage" of the technique.
Results
Control group. Serial changes in mean aortic pressure and mean distal LAD coronary perfusion during baseline conditions, 10 min after 2011 administration with the LAD stenosis in place, and 2 hr after 201T1 administration, are shown in figure 2. In these nine animals there was no significant change in mean aortic pressure with the LAD stenosis. However, there was a slight but significant fall in mean aortic pressure 2 hr after 201T1 administration. The mean distal LAD coronary perfusion pressure fell from 102 ± 4 (SE) to 74 ± 4 mm Hg with the stenosis in place in these animals. At 2 hr the distal coronary pressure was unchanged at 72 ± 4 mm Hg. Mean electromagnetically determined coronary flow was 58 + 8 and 50 ± 8 ml/min at baseline and stenotic conditions, respectively (NS). Mean heart rate was 143 ± 4 beats/min at baseline conditions and was unchanged at 143 ± 4 beats/min after production of the stenosis. At 2 hr the heart rate was slightly lower at 136 Dipyridamole group. Figure 6 summarizes the values for mean aortic pressure, mean distal coronary perfusion pressure, and electromagnetically determined flow in the 12 dogs receiving 0. 15 mg/kg dipyridamole before 20 Tl administration. As shown, the stenosis resulted in a slight but significant fall in mean aortic pressure (110 + 3.6 to 100 ± 3.9 mm Hg; p = .001). A further fall in mean aortic pressure to 86 ± 3.2 mm Hg (p < .0001) was evident after dipyridamole infu- sion. Two hours after dipyridamole, aortic pressure rose to 91 ± 3.9 mm Hg (NS). The mean distal coronary perfusion pressure before stenosis (control) was 104 ± 4 mm Hg and fell significantly to 64 + 3 mm Hg after production of the stenosis (p < .0001). With dipyridamole infusion, the distal coronary perfusion pressure fell even further to 48 ± 3 mm Hg (p < .0001). Two hours after the 1 min dipyridamole infusion, the distal pressure returned to 62 ± 3 mm Hg. The mean LAD perfusion pressure with the stenosis in place, and before dipyridamole, was not significantly different from that in the nine control dogs, indicating that severity of the stenosis was comparable in the two groups. As pressures, flow was not significantly altered after dipyridamole infusion (55 ± 5 vs 50 ± 6 ml/min). Similarly, the mean heart rate was not significantly altered after dipyridamole infusion compared with that under stenotic conditions before infusion (140 ± 4 vs 140 ± 5 beats/min).
As shown in figure 7 , in the 12 dogs receiving dipyridamole 201T1 activity at 10 min in the stenotic zone was reduced to 42 ± 5% of initial normal zone activity (p < .001) and remained at 44 ± 3% of initial activity in the normal zone at 2 hr. In contrast, the 201T1 clearance was rapid in the normal zone, with 201T1 activity decreasing to 55 + 3% of initial normal activity by 2 hr. Thus there was a 45% decrease in 20Tl activity in the normal myocardial region as compared with no net change in activity in the stenotic region (flat clearance). This inhomogeneous early uptake and differential clearance from the two regions produced a redistribution pattern in which near-normalization of activity was achieved. These myocardial time-activity curves differ markedly from those plotted for the nine control dogs (figure 3), in which no initial decrease in 201T1 activity was observed in the stenotic region and clearance patterns were identical in normal and stenotic regions.
Epicardial and endocardial regional flow values in normal and stenotic regions before dipyridamole infusion, at peak dipyridamole effect and at 2 hr after dipyridamole infusion, are summarized in figures 8 and 9. In the normal region, dipyridamole increased epicardial flow from 1.03 ± 0.09 to 3.52 ± 0.36 ml/ min/g (p < .0001) and endocardial flow from 1.19 + 0.09 to 2.96 ± 0.20 ml/min/g (p = .0001). In contrast, in the stenotic region, epicardial flow after dipy- ridamole increased to a lesser extent, from 1.01 ± 0. 10 to 1.55 ± 0. 15 ml/min/g (p = .009). Endocardial blood flow in the stenotic region significantly decreased with dipyridamole infusion from 0.84 + 0. 11 to 0.64 ± 0.15 ml/min/g (p -.04). At 2 hr after infusion, regional myocardial blood flow in epicardial and endocardial zones of both regions returned toward the baseline prevasodilatory state with the stenosis still in place. The only exception was that endocardial blood flow in the stenotic region 2 hr after dipyridamole (0.69 + 0.06 ml/min/g) was not significantly different from that at peak dipyridamole effect. Relationship between 201TI uptake and percent reduction in maximum hyperemic flow. We sought to determine whether or not the magnitude of 201T1 diminution in the stenotic region after dipyridamole correlated quantitatively with the physiologic or functional severity of the partial obstruction. Figure 10 demonstrates that good correlation exists (r = .81) between the percent reduction in 201TI uptake at 10 min and the percent reduction of peak hyperemic flow, as determined by measuring the percentage difference in peak flow after a transient 10 sec occlusion under control and stenotic conditions. The horizontal axis on this plot (figure 10) represents the ratio of peak hyperemic flow with the partial stenosis to the peak hyperemic flow of the vessel at baseline indicate that the mean variation between the duplicate 201TI determinations at biopsy was between 3% and 4%.
To determine whether regional blood flow was relatively homogeneous within the regions examined at biopsy, the final 120 min transmural flow values for the myocardial specimens containing the 10, 60, and 120 min needle biopsy sites were compared. Table 1 shows that the regional flow at 120 min after 201TI administration was comparable in the myocardial specimens with needle-puncture sites and not significantly different from the flow in the immediately adjacent samples. This homogeneity of flow was observed within both the nonischemic and stenotic regions, although absolute flow was lower in myocardium perfused by the critically stenosed LAD as expected. If trauma or hemorrhage had occurred with the 10, 60, or 120 min needle biopsies, one might have expected the flow at 120 min to have been altered in the transmural specimens from which the biopsy samples were acquired in vivo.
Discussion
The results of this study demonstrate that dipyridamole-induced vasodilation in the presence of a partial coronary stenosis resulted in diminished uptake and delayed clearance of intravenously administered 20T1, compared with increased uptake and more rapid clearance of the radionuclide in normally perfused myocardium, producing an initial 201T1 defect with delayed redistribution. Percent reduction of initial 201TI uptake with dipyridamole infusion was proportional to the diminution in coronary reserve capacity as gauged by the percent reduction in peak hyperemic flow produced by the given coronary stenosis. In a group of control animals with coronary stenoses of physiologic severity similar to that in the dogs receiving dipyridamole, no initial defect in 201T1 uptake was observed and net clearance rates were identical from myocardium perfused by the patent circumflex coronary artery and myocardium perfused by the stenotic LAD.
In 1977, Strauss and Pitt'8 administered microspheres radiolabeled with 201TI after intravenous adenosine infusion to dogs with a subcritical left circumflex stenosis in which resting flow was not diminished. They demonstrated perfusion defects on images with vasodilator administration, which was associated with a fall in the left circumflex-to-LAD bed flow ratio. Several groups have further investigated the effects of coronary vasodilation on 207T1 kinetics in canine preparations. Strauer et al. 19 showed that the dipyridamoleenhanced 207T1 uptake in normal myocardium was independent of an increase in myocardial oxygen demand. Gould endocardial surface of the left ventricle. Nishiyama et al.20 injected 207T1 intravenously during peak reactive hyperemia after a transient circumflex coronary occlusion and showed that subsequent myocardial 20'Tl clearance was more rapid with a half-life of 3.4 hr compared with 11 hr in ischemic myocardial regions. The results of our experiments, as well as the results of those described above, show that dipyridamole infusion results in greatly increased blood flow in normal vessels but no increase in total coronary flow in the critically stenosed vessel. Although total coronary flow measured with the flowmeter was unaltered by dipyridamole, there was increased epicardial flow but decreased endocardial flow, producing an adverse endocardial/epicardial flow gradient in myocardium distal to the stenosis. This has been referred to as "coronary steal."21 The mechanism of "steal" in the setting of a single-vessel stenosis is not entirely clear. There was a striking reduction in perfusion pressure distal to the stenosis, perhaps related in part to the fall in aortic pressure produced by the drug. It may be that the reduced perfusion pressure is adequate to maintain increased blood flow in the epicardium but insufficient to provide adequate subendocardial flow.
For this study, the following definition of "physiologic severity" of a coronary stenosis was adopted.
The maximum blood flow capacity of the vessel in the unstenosed state was first measured with the electromagnetic flowmeter at peak reactive hyperemic flow after a 10 sec temporary occlusion. This was considered to be the peak blood flow capacity of the unobstructed vessel. After the partial stenosis was established, peak flow was recorded after another 10 sec temporary occlusion. If, for example, this was onehalf the value obtained for the unobstructed vessel, the stenosis was characterized by the value of 0.5, indicating that the effect of the stenosis was to reduce the peak blood flow capacity of this vessel in response to ischemic challenge to 50% of its original capacity. These values were compared to the biopsy-determined magnitude of the 20'Tl defect obtained after dipyridamoleinduced vasodilation with the same stenosis in place. This definition was adopted to characterize the actual hemodynamic impact of the obstruction independent of its anatomic structure. In addition, this ratio is independent of vascular tone or the absolute blood flow in the vessel, which would depend on the amount of myocardium supplied by the individual vessel.
The 201T1 activity in this study was determined from the results of transmural biopsies that averaged the epicardial and endocardial regions, as would be the case in most clinical imaging studies. For this type of sampling, the initial uptake of 201TI would be expected to reasonably reflect the distribution of total coronary arterial flow as divided between the normal and stenosed vessels.22-25 The early uptake of 201T1 with dipyridamole infusion in the present study was indeed shown to significantly diminish in the stenotic region sampled relative to nonischemic 201T1 activity.
The observation of delayed net 201T1 clearance in this and prior studies'4 15 from a compromised vascular region after dipyridamole infusion is further evidence of physiologically significant hypoperfusion induced by the vasodilator. After dipyridamole infusion, the net 20'Tl clearance from myocardium perfused by the stenotic LAD was slower (see figure 7 ) than that in a similarly compromised myocardial region without dipyridamole (see figure 3 ). This occurred despite the fact that total coronary flow (measured electromagnetically) through the stenotic LAD was comparable in control dogs and dogs receiving dipyridamole when the 201TI was administered. The observation of slower net 20'Tl clearance in dogs receiving dipyridamole is inconsistent with a model which assumes that the cellular efflux of 201T1 is directly proportional to a constant rate coefficient in product with the local intracellular 201TI concentration. If the rate transport coefficient remained constant, the total integrated efflux of 201T1 throughout the transmural myocardial region would be independent of the manner in which 201TI was distributed within that region and thus would be independent of the endocardium-to-epicardium flow inhomogeneity induced by dipyridamole. If, in addition, it is assumed that the average extraction coefficient within the myocardial region is not significantly altered by dipyridamole, the net clearance of 201T1 from myocardium perfused by the stenotic vessel should not be any slower than that from the similarly stenosed region without dipyridamole.
From the above argument, it must be concluded that either the average extraction of 201T1 must increase or the cellular efflux or intrinsic washout of 20'TI must be slowed in the stenotic region in the presence of dipyridamole to explain the slower net clearance of 1'0Tl in dogs receiving the vasodilator. The influence of hypoperfusion on initial extraction and subsequent intrinsic washout of 201TI was previously examined in a canine preparation by means of a graded reduction in transmural myocardial flow produced by a hydraulic occluder around the LAD. 26 The intrinsic washout rate of 20 figure 7 .
Clinical implications. A number of clinical studies have been published that deal with the utility of myocardial imaging after dipyridamole for detection of coronary artery disease. -'2 17 As expected from the animal kinetic data, myocardial defects are observed on images in patients receiving intravenous dipyridamole before 201Tl administration. Delayed redistribution, when sought for, has been reported to occur on subsequent images in those regions demonstrating initial defects as long as no myocardial scar is present. I Some patients receiving dipyridamole even manifest clinical ischemia, reflected by the development of angina and ST segment depression 28-30 These latter manifestations of drug infusion surely must be related to the fall in subendocardial blood flow that is evident in the presence of a critical stenosis when maximum vasodilation is induced.3' -4 Francisco et al. 12 observed 20Tl defects in the distribution of some mild stenoses of 30% to 50% diameter narrowing in patients by means of dipyridamole stress. These investigators, using a dose of dipyridamole in patients comparable to that used in these experiments, reported a 90% sensitivity and 90% specificity for tomographic 201Tl imaging with dipyridamole in patients with chest pain who were being evaluated for the presence of coronary artery disease. Other clinical studies report comparable sensitivities between dipyridamole imaging and exercise imaging for detection of coronary narrowings of 50% or greater in diameter.9
There are certain hypothetical advantages of dipyridamole stress over exercise testing. The maximum coronary flow achieved may be greater than that achieved with exercise alone.4 Gould et al.1 2 demonstrated in an animal preparation that myocardial perfusion imaging with 201TI during coronary vasodilation induced by intravenous dipyridamole was better for identifying moderate coronary stenoses than exercise.
Based on the observations made in the present canine experiments, further clinical studies appear warranted to determine whether dipyridamole 20TI scintigraphy can be used to measure the physiologic or functional severity of coronary stenoses in humans by means of imaging data obtained from both the initial distribution phase and the subsequent clearance phase.
Thus these experimental studies demonstrate that with a vasodilator-induced increase in coronary blood flow, the initial uptake of 20ITI is reduced in regions supplied by a coronary stenosis, whereas 207T1 uptake is enhanced in regions receiving an increase in flow. Subsequently redistribution occurs because of disparate clearance rates from hyperperfused and relatively hypoperfused myocardial regions. The near total delayed redistribution in these dogs was related to a more rapid clearance of 20ITl from the zone perfused by the patent left circumflex coronary artery and a delayed or flat clearance of 20T1 in the hypoperfused region perfused by the stenosed LAD. This abnormal net clearance of 20Tl may be related to an altered intrinsic cellular efflux rate of 201TI in subendocardial regions rendered ischemic by the vasodilator. Our data further demonstrate that the magnitude of the initial decrease in 201TI uptake after dipyridamole infusion correlates well with severity of stenosis.
intravenous dipyridamole on regional coronary hemodynamics and metabolism. 
